0001209191-22-055407.txt : 20221102
0001209191-22-055407.hdr.sgml : 20221102
20221102190949
ACCESSION NUMBER: 0001209191-22-055407
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221031
FILED AS OF DATE: 20221102
DATE AS OF CHANGE: 20221102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Azelby Robert
CENTRAL INDEX KEY: 0001656998
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40708
FILM NUMBER: 221355661
MAIL ADDRESS:
STREET 1: 307 WESTLAKE AVE. NORTH, STE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eliem Therapeutics, Inc.
CENTRAL INDEX KEY: 0001768446
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832273741
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 23515 NE NOVELTY HILL ROAD
STREET 2: SUITE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
BUSINESS PHONE: 425-276-2300
MAIL ADDRESS:
STREET 1: 23515 NE NOVELTY HILL ROAD
STREET 2: SUITE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-31
0
0001768446
Eliem Therapeutics, Inc.
ELYM
0001656998
Azelby Robert
C/O ELIEM THERAPEUTICS, INC.
23515 NE NOVELTY HILL RD, STE. B221 #125
REDMOND
WA
98053
1
1
0
0
President & CEO
Stock Option (Right to Buy)
3.27
2022-10-31
4
A
0
500000
0.00
A
2032-10-30
Common Stock
500000
500000
D
The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of October 31, 2022 (the "2022 Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2022 Vesting Commencement Date.
/s/ Alan Hambelton, Attorney-in-Fact
2022-11-02